Evidence map›Paper›PMID 25129849›Full record

ArticleJournal of psychosomatic research2014

Severe depressive symptoms are associated with elevated endothelin-1 in younger patients with acute coronary syndrome.

Luba Yammine, Lorraine Frazier, Nikhil S Padhye, Matthew M Burg, Janet C Meininger

Abstract read
In one paragraph

Article in Journal of psychosomatic research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Crosstalk Among NLRP3 Inflammasome, ETNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
  4. Article
  5. Article
  6. Observational
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Luba YammineUniversity of Texas Health Science Center at Houston, United States. Electronic address: Luba.Yammine@uth.tmc.edu.
Lorraine FrazierUniversity of Arkansas for Medical Sciences, Little Rock, United States.
Nikhil S PadhyeUniversity of Texas Health Science Center at Houston, United States.
Matthew M BurgColumbia University, Center for Behavioral Cardiovascular Health, United States; Yale University, Section of Cardiovascular Medicine, United States.
Janet C MeiningerUniversity of Texas Health Science Center at Houston, United States.
The University of Texas Health Science Center at Houston · USUniversity of Arkansas for Medical Sciences · USYale University · US

Funding

Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
Interactions among Depressive Symptoms and Genetic Influences on Cardiac OutcomesR01NR010235 · NINR · UNIV OF ARKANSAS FOR MED SCIS · PI FRAZIER, LORRAINE Q. · 2007 to 2011
$2.6M
NCATS NIH HHS UL1 TR000371NINR NIH HHS 1R01NR010235-01A1NINR NIH HHS R01 NR010235
6 · The paper itself

Abstract

objectiveTo explore the relationship of depressive symptom severity to circulating endothelin (ET)-1 in younger patients with acute coronary syndrome (ACS). Younger patients report greater depressive symptom severity, which predicts poorer post-ACS prognosis. The pathways linking depression to post-ACS prognosis require further elucidation. ET-1 is a potent endogenous vasoconstrictor which has been previously linked to adverse post-ACS outcomes.

methodsThe sample (n=153) included males ≤ 50 years of age and females ≤ 55 years of age who participated in a larger study. Blood samples for ET-1 assessment were collected within 2-3h of ACS admission. Depressive symptoms were assessed with the Beck Depression Inventory (BDI) II within 2-5 days of admission. ET-1 was treated as a transformed continuous variable (ET-1T). BDI-II scores were classified into four categories using conventional thresholds demarcating mild, moderate, and severe levels of depressive symptoms. The relationship of classified BDI-II score to ET-1T was examined in simple and multivariable linear regression models.

resultsClassified BDI-II score was related to ET-1T in both unadjusted (χ(2)=9.469, p=0.024) and multivariable (χ(2)=8.430, p=0.038) models, with ET-1T being significantly higher in patients with severe depressive symptoms than in those with mild and moderate depressive symptoms.

conclusionsIn this sample of younger post-ACS patients, severe depressive symptoms were associated with elevated ET-1. We acknowledge that the observed association could be eliminated by the inclusion of some unmeasured variable(s). Longitudinal research should examine whether ET-1 mediates the relationship of depressive symptoms to long-term post-ACS outcomes.

Indexed as

Acute Coronary SyndromeBiomarkersDepressionEndothelin-1FemaleHumansLinear ModelsMaleMiddle AgedPatient AdmissionPrognosisPsychiatric Status Rating ScalesSeverity of Illness IndexBiomarkersEndothelin-1Acute coronary syndromeDepressionDepressive symptomsEndothelinMyocardial infarctionYounger patients

Identifiers

PMID25129849
PMCPMC4252375
OpenAlexW2010023201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.